Sign in

CIK 0000908259

  • Non-accelerated filer
  • Smaller reporting company

Oncotelic Therapeutics, Inc.

Sign in to watch
Ticker
OTLC
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133679168
Phone
+1 650-635-7000
Business address
29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
Former names
MATEON THERAPEUTICS INC, OXIGENE INC
Open-market buys, last 90 days
$23,537
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Trieu Vuong +$24K CHAIRMAN AND CEO 1 filing

Reading 71 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-20 LOAR MATTHEW M Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +250,000 250,000
2018-06-20 LOAR MATTHEW M Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +500,000 500,000
2018-04-12 LOAR MATTHEW M Chief Financial Officer Purchase +250,000 300,000
2018-04-12 LOAR MATTHEW M Chief Financial Officer Purchase · Common Stock A Warrant (Right to Buy) +125,000 125,000
2018-04-12 LOAR MATTHEW M Chief Financial Officer Purchase · Common Stock B Warrant (Right to Buy) +125,000 125,000
2017-01-12 LOAR MATTHEW M Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +350,000 $0.38 $131K 350,000
2016-03-21 LOAR MATTHEW M Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +262,500 262,500
2015-07-20 LOAR MATTHEW M Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +150,000 150,000

Page 1 of 1 · 8 trades